Our thorough case investigations have spanned the country and resulted in incredible recoveries for our clients.

Our skill set and experience set us apart from our competition as one of the premier law firms not only in the United States, but worldwide.

plus icon

Connect with Kaplan Fox.

Receive a complimentary case review now.

Contact Us
Axos Financial

Axos Financial, Inc.

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Axos Financial, Inc. (“Axos” or the “Company”) (NYSE: AX). Click here to join the investigation….

Read MoreJoin Investigation
autodesk

Autodesk, Inc. 

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Autodesk, Inc.  (“Autodesk” or the “Company”) (NASDAQ: ADSK) securities between June 1, 2023 and April 16, 2024 (the “Class Period”).  Click Here to Join Investigation….

Read MoreJoin Investigation
compass minerals

Compass Minerals International, Inc.

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Compass Minerals International, Inc. (“Compass Minerals” or the “Company”) (NYSE: CMP) securities between November 29, 2023 and March 22, 2024 (the “Class Period”).  Click Here to Join Investigation….

Read MoreJoin Investigation
ast spacemobile

AST SpaceMobile, Inc.

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of AST SpaceMobile, Inc. (“SpaceMobile” or the “Company”) (NASDAQ: ASTS) securities between November 14, 2023 and April 1, 2024 (the “Class Period”).  Click Here to Join Investigation….

Read MoreJoin Investigation
Checkpoint Therapeutics

Checkpoint Therapeutics, Inc.

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT) securities between March 10, 2021 and December 15, 2023 (the “Class Period”).  Click Here to Join Investigation. …

Read MoreJoin Investigation
Chemours

The Chemours Company

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”)(NYSE: CC). Click Here To Join Investigation….

Read MoreJoin Investigation
Medical scrubs hanging in medical office.

Doximity, Inc.

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of the common stock of Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) between February 9, 2022 and April 1, 2024 (the “Class Period”)….

Read MoreJoin Investigation
1 … 3 4 5 6